36
Views
27
CrossRef citations to date
0
Altmetric
Original Article

Urinary Excretion of Citrate, Glycosaminoglycans, Magnesium and Zinc in Relation to Age and Sex in Normal Subjects and in Patients who form Calcium Stones

, , , &
Pages 379-386 | Received 17 May 1991, Accepted 11 Nov 1991, Published online: 15 Feb 2010

REFERENCES

  • BirdED, ThomasWC. Effect of various metals on mineralization in vitro. Soc Exp Biol Med 1963; 112: 640–643.
  • BisazS, FelixR, NeumanWF, FleischH. Quantitative determination of inhibitors of calcium phosphate precipitation in whole urine. Min Electrolyte Metab 1978; 1: 74–83.
  • BreslauNA, BrinkleyL, HillKD, PakCYC. Relationship of animal protein-rich diet to kidney stone formation and calcium metabolism. J Clin Endocrinol Metab 1988; 6: 140.
  • BusherGL, LockwoodTJ, CochraneHR, DelvesHT, HallMRP. Serum zinc in old age. J Clin Exp Gerontol 1982; 4: 249–256.
  • ConwayNS, MaitlandAIL, RennieJ. The urinary citrate excretion in patients with renal calculi. Br J Urol 1949; 21: 30–38.
  • DanielsonBG, JohanssonG, LjunghallS. Magnesium metabolism in healthy subjects. Scand J Urol Nephrol 1979; Suppl 51: 49–73.
  • DesmarsJF, TawashiR. Dissolution and growth of calcium oxalate monohydrate. I. Effect of magnesium and pH. Biochim Biophys Acta 1973; 313: 256–267.
  • DrachGW. Is magnesium metabolism related to calcium urolithiasis? Urol Res 1988; 12: 63.
  • FleischH. Inhibitors and promotors of stone formation. Kidney Int 1978; 13: 361–371.
  • FrançoisR, CahenR, PascalB. Inhibitors of urinary stone formation in 40 recurrent stone formers. Br J Urol 1986; 58: 479–483.
  • HammarML, BergGE, LarssonL, TiseliusHG, VarenhorstE. Endocrine changes and urinary excretion. Scand J Urol Nephrol 1987; 21: 51–53.
  • HastingsBA, McLeanFC, EichelbergerL, HallJL, DaCosta E. The ionization of calcium, magnesium and strontium citrates. J Biol Chem 1934; 107: 351–370.
  • HodgkinsonA. Citric acid excretion in normal adults and in patients with renal calculus. Clin Sci 1962; 23: 203–212.
  • HodgkinsonA. The relation between citric acid and calcium metabolism with particular reference to primary hyperparathyroidism and idiopathic hypercalciuria. Clin Sci 1963; 24: 167–178.
  • HodgkinsonA. Relations between oxalic acid, calcium, magnesium and creatinine excretion in normal men and male patients with calcium oxalate kidney stones. Clin Sci Mol Med 1974; 46: 357–367.
  • HwangTIS, PremingerGM, PoindexterJ, PakCYC. Urinary glycosaminoglycans in normal subjects and patients with stones. J Urol 1988; 139: 995–997.
  • JohanssonG, BackmanU, DanielsonBG, LjunghallS, WikströmB. Magnesium metabolism in renal stone disease. Invest Urol 1980; 18: 93–96.
  • KokDJ, PapapoulosSE, BijovoetOLM. Excessive crystal agglomeration with low citrate excretion in recurrent stone-formers. Lancet 1986; 1: 1056–1058.
  • MeyerJL, SmithLH. Growth of calcium oxalate cystals. II. Inhibition by natural urinary crystal growth inhibitors. Invest Urol 1975; 13: 31–35.
  • MenonM, MahleCJ. Urinary citrate excretion in patients with renal calculi. J Urol 1983; 129: 1158–1160.
  • NicarMJ, SkurlaC, SakhaeeK, PakCYC. Low urinary citrate excretion in nephrolithiasis. Urology 1983; 21: 8–14.
  • OreopoulosDG, SoyannwoMAO, McGeownMG. Magnesium excretion after calcium infusion, and the significance of the Mg/Ca ratio in patients with renal stones. Lancet 1968; 2: 420–422.
  • ParksJH, CoeFL. A urinary calcium-citrate index for the evaluation of nephrolithiasis. Kidney Int 1986; 30: 85–90.
  • RobertsonWG, PeacockM, HeyburnPJ, MarshallDH, ClarkPB. Risk factors in calcium stone disease of the urinary tract. Br J Urol 1978; 50: 449–454.
  • RudmanD, KutnerMH, ReddII SC, WatersIV WC, GerronGG, BleierJ. Hypocitraturia in calcium nephrolithiasis. J Clin Endocrinol Metab 1982; 55: 1052–1057.
  • RyallRL, HarnettRM, HibberdCM, MazzachiBC, MazzachiRD, MarshallVR. Urinary risk factors in calcium oxalate stone disease: comparison of men and women. Br J Urol 1987; 60: 480–488.
  • SamuellCT. A study of glycosaminoglycan excretion in normal and stone-forming subjects using a modified cetylpyridinium chloride technique. Clin Chim Acta 1981; 117: 63–73.
  • SchwillePO, ScholzD, SchwilleK, LeutschaftR, GoldbergI, SigelA. Citrate in urine and serum and associated variables in subgroups of urolithiasis. Results from an outpatient stone clinic. Nephron 1982; 310: 194–202.
  • SenapatiA, JennerG, ThompsonRPH. Zinc in the elderly. Quart J Med 1989; 61: 81–87.
  • ShorrE, BernheimAR, TausskyH. The relation of urinary citric acid excretion to the menstrual cycle and the steroidal reproductive hormones. Science 1942; 95: 606–607.
  • SutorDJ, PercivalJM, DoonanS. Isolation and identification of some urinary inhibitors of calcium phosphate formations. Clin Chim Acta 1978; 89: 273–278.
  • TiseliusH–G, AlmgårdLE, LarssonL, SorboB. A biochemical basis for grouping of patients with urolithiasis. Eur Urol 1978; 4: 241–249.
  • WelshmanSG, McGeownMG. Urinary citrate excretion in stone-formers and normal controls. Br J Urol 1976; 48: 7–11.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.